Consumers can have their whole exomes sequenced at Genos.
Consumers OWN their data!

Researchers can also work with Genos to recruit participants for studies and Genos handles the entire participant recruitment process, from finding participants, registration, and sequencing through data delivery, and liberates researchers from tedious admin work.

We require 75x on-target depth (after reads are adapter masked, mapped, duplicates removed.), which is defined as on-target yield / target size. The raw throughput (raw data off the sequencer) may have about 130x-140x or higher.

We also have very high requirements on uniformity, e.g. very high percentage requirements on 1x and 20x loci. We will communicate the numbers individually for now. The uniformity requirements is higher than most of research projects published.

We require samples have to match BOTH 75x and uniformity requirements.

Deliverable to consumers: VCF (with SNP and indels and no-calls (regions not covered by sequencing or not confident to call))

Deliverables to researchers: (if the researcher sets up a study and consumers contribute and consent to give their data): VCF, self reported phenotypic data.

Thanks for asking this question because our principle of data ownership truly differentiates us from other companies.

One of our core principles is that Genos does not claim any ownership of a userís genetic data in any capacity and that participant's data remains the property of the user, NOT Genos.

Genos will only share the data with researchers with whom the user has specifically consented to share data. A user is also free to download and export the data and port their genomes to other content providers and may ask Genos to delete the account and remove the data from our platform at any time. More details are available in our Terms of Service.

Quote:

Originally Posted by bruce01

Owning data legally requires ultimate control and exclusive rights of use. Does Genos relinquish rights of use and all control of the data?